当前位置:首页 - 行情中心 - 锦波生物(920982) - 财务分析 - 现金流量表

锦波生物

(920982)

  

流通市值:68.44亿  总市值:141.99亿
流通股本:5546.51万   总股本:1.15亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金806,037,728.8405,889,896.041,719,652,110.941,336,271,300.35
  收到其他与经营活动有关的现金15,514,551.4412,166,278.7464,197,483.0844,272,434.72
  经营活动现金流入小计821,552,280.24418,056,174.781,783,849,594.021,380,543,735.07
  购买商品、接受劳务支付的现金70,310,116.0836,937,519.67186,092,420.47125,168,020.01
  支付给职工以及为职工支付的现金145,567,492.4375,257,815.35269,313,846.67206,071,312.61
  支付的各项税费119,893,261.7952,202,181.81326,124,778.06231,084,952.12
  支付其他与经营活动有关的现金192,755,777.5790,609,161.58372,316,358.83263,996,231.13
  经营活动现金流出小计528,526,647.87255,006,678.411,153,847,404.03826,320,515.87
  经营活动产生的现金流量净额293,025,632.37163,049,496.37630,002,189.99554,223,219.2
二、投资活动产生的现金流量:
  收回投资收到的现金1,450,000,000800,000,0002,400,000,0001,650,000,000
  取得投资收益收到的现金4,873,311.792,052,393.986,278,637.94,889,164.88
  处置固定资产、无形资产和其他长期资产收回的现金净额--900-
  投资活动现金流入小计1,454,873,311.79802,052,393.982,406,279,537.91,654,889,164.88
  购建固定资产、无形资产和其他长期资产支付的现金70,311,437.7735,232,150.81370,322,228.53279,959,008.52
  投资支付的现金1,450,000,000800,000,0002,430,700,0001,680,000,000
  投资活动现金流出小计1,520,311,437.77835,232,150.812,801,022,228.531,959,959,008.52
  投资活动产生的现金流量净额-65,438,125.98-33,179,756.83-394,742,690.63-305,069,843.64
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,000,0001,000,0008,900,0005,900,000
  其中:子公司吸收少数股东投资收到的现金1,000,0001,000,0008,900,0005,900,000
  取得借款收到的现金80,000,000-143,000,000-
  收到其他与筹资活动有关的现金--3,500,0003,500,000
  筹资活动现金流入小计81,000,0001,000,000155,400,0009,400,000
  偿还债务支付的现金10,500,0003,500,00037,801,12921,310,171
  分配股利、利润或偿付利息支付的现金60,047,247.081,279,713.19294,520,199.19294,019,083.36
  支付其他与筹资活动有关的现金84,291,196.611,190,263.87,183,971.454,574,478.9
  筹资活动现金流出小计154,838,443.695,969,976.99339,505,299.64319,903,733.26
  筹资活动产生的现金流量净额-73,838,443.69-4,969,976.99-184,105,299.64-310,503,733.26
四、汇率变动对现金及现金等价物的影响-474,187.92-121,397.27-131,991.98-56,021.17
五、现金及现金等价物净增加额153,274,874.78124,778,365.2851,022,207.74-61,406,378.87
  加:期初现金及现金等价物余额992,146,971.14992,146,971.14941,124,763.4941,124,763.4
  期末现金及现金等价物余额1,145,421,845.921,116,925,336.42992,146,971.14879,718,384.53
补充资料:
  净利润282,159,334.78-645,710,506.58-
  资产减值准备1,216,013.93-23,085,134.39-
  固定资产和投资性房地产折旧35,998,749.52-56,661,582.85-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧35,998,749.52-56,661,582.85-
  无形资产摊销4,660,754.92-11,700,720.56-
  长期待摊费用摊销2,972,431.16-4,094,206.3-
  固定资产报废损失812,690.88-1,635,495.87-
  财务费用6,104,960.38-7,519,786.63-
  投资损失-4,822,721.42--6,176,174.86-
  递延所得税-1,594,097.95--4,626,236.92-
  其中:递延所得税资产减少-1,449,276.39--4,336,593.8-
    递延所得税负债增加-144,821.56--289,643.12-
  存货的减少26,739,834.08--94,383,162.15-
  经营性应收项目的减少-87,421,084.01--72,102,365.54-
  经营性应付项目的增加15,781,082.72-38,610,817.78-
  其他-5,272,648.24--3,862,298.89-
  不涉及现金收支的投资和筹资活动金额其他项目--5,512,327.31-
  现金的期末余额1,145,421,845.92-992,146,971.14-
  减:现金的期初余额992,146,971.14-941,124,763.4-
  现金及现金等价物的净增加额153,274,874.78-51,022,207.74-
公告日期2026-08-252026-04-292026-04-292025-10-29
审计意见(境内)标准无保留意见
TOP↑